文献速递前列腺癌

良性、Gleason 3 型和 4 型前列腺组织体积与血前列腺特异性抗原的关系

Blood Prostate-specific Antigen by Volume of Benign, Gleason Pattern 3 and 4 Prostate Tissue.
PubMed 文献 · Urology · 2022-08-17

研究纳入 2 所学术机构连续接受根治性前列腺切除术的 2209 例 pT2N0、Grade Group 1-4 且术后 PSA 不可测的前列腺癌患者,评估血 PSA 与良性组织、Gleason 3 型(GP3)和 4 型(GP4)体积的关系。结果显示 GP4 每单位体积对 PSA 的贡献远高于 GP3 和良性组织,GP3 与良性组织的贡献相似。

要点

  • GP4 每 cc 贡献的 PSA 是 GP3 的 6 至 8 倍,是良性组织的 15 倍。
  • GP3 与良性组织每 cc 的 PSA 贡献无显著差异(P = 0.2)。
  • PSA 密度与 GP4 体积相关,调整良性组织体积后与 GP3 体积不相关。

核心结论

  • Gleason 4 型癌每单位体积对 PSA 和 PSA 密度的贡献远大于 GP3 和良性组织,GP3 与良性组织的贡献相似。
  • 作者建议进一步研究以 GP4 绝对体积而非 GP3 与 GP4 比值来制定临床管理推荐。

研究设计与样本

  • 队列研究纳入 2 所学术机构连续接受根治性前列腺切除术的 2209 例 pT2N0、Grade Group 1-4 且术后 PSA 不可测的前列腺癌患者。
  • 估计良性组织、GP3 和 GP4 的体积,采用多变量线性回归评估 PSA 与各组织体积的关联并计算 R2。

主要发现

  • 两个独立队列中,每 cc 组织对 PSA 的估计贡献分别为:良性组织 0.04/0.06 ng/mL/cc,GP3 0.08/0.14 ng/mL/cc,GP4 0.62/0.80 ng/mL/cc。
  • GP4 每 cc 贡献的 PSA 较 GP3 高 6 至 8 倍,较良性组织高 15 倍。
  • GP3 与良性组织每 cc 的 PSA 贡献无显著差异(P = 0.2)。
  • 从模型中移除年龄、良性组织体积或 GP3 时 R2 仅小幅下降(分别为 0.006/0.018、0.051/0.054、0.014/0.023);移除 GP4 时 R2 下降 0.051/0.310。
  • 调整良性组织体积后,PSA 密度与 GP4 体积相关,与 GP3 体积不相关。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文结论指出需进一步研究以 GP4 绝对体积而非 GP3 与 GP4 比值来制定临床管理推荐。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate how blood levels of prostate-specific antigen (PSA) relate to prostate volume of benign tissue, Gleason pattern 3 (GP3) and Gleason pattern 4 (GP4) cancer. METHODS: The cohort included 2209 consecutive men undergoing radical prostatectomy at 2 academic institutions with pT2N0, Grade Group 1-4 prostate cancer and an undetectable postoperative PSA. Volume of benign, GP3, and GP4 were estimated. The primary analysis evaluated the association between PSA and volume of each type of tissue using multivariable linear regression. R2, a measure of explained variation, was calculated using a multivariable model. RESULTS: Estimated contribution to PSA was 0.04/0.06 ng/mL/cc for benign, 0.08/0.14 ng/mL/cc for GP3, and 0.62/0.80 ng/ml/cc for GP4 for the 2 independent cohorts, respectively. GP4 was associated with 6 to 8-fold more PSA per cc compared to GP3 and 15-fold higher compared to benign tissue. We did not observe a difference between PSA per cc for GP3 vs. benign tissue (P = 0.2). R2 decreased only slightly when removing age (0.006/0.018), volume of benign tissue (0.051/0.054) or GP3 (0.014/0.023) from the model. When GP4 was removed, R2 decreased 0.051/0.310. PSA density (PSA divided by prostate volume) was associated with volume of GP4 but not GP3, after adjustment for benign volume. CONCLUSION: Gleason pattern 4 cancer contributes considerably more to PSA and PSA density per unit volume compared to GP3 and benign tissue. Contributions from GP3 and benign are similar. Further research should examine the utility of determining clinical management recommendations by absolute volume of GP4 rather than the ratio of GP3 to GP4.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Andolfi C, Vickers AJ, Cooperberg MR, et al. Blood Prostate-specific Antigen by Volume of Benign, Gleason Pattern 3 and 4 Prostate Tissue. Urology. 2022. PMID: 35987380. doi:10.1016/j.urology.2022.08.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。